
AI-Designed Drug Shows Promising Early Results in Mesothelioma Clinical Trial
An investigational drug developed using generative artificial intelligence demonstrated tumor-shrinking activity in patients with heavily pretreated mesothelioma, offering another encouraging development in the search for






